Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Mar 26, 2010

Premium

Bio-Rad Laboratories said this week that Ted Love has been appointed to its board of directors, bringing the company back into compliance with New York Stock Exchange listing requirements.

Love will be on the board's audit committee. The NYSE requires a listed company to have three independent directors on its audit committee.

Love is the executive vice president of R&D at Onyx Pharmaceuticals. Prior to that, he was president, CEO, and a board member of Nuvelo. He will stand for election along with Bio-Rad's other board members at the company's annual meeting on April 27.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.